ENvue Medical (FEED) Income from Continuing Operations (2014 - 2026)
ENvue Medical's (FEED) quarterly Income from Continuing Operations came in at -$4.9 million in Q2 2026, down 23.37% year-over-year from -$6.4 million in Q2 2025, and down 28.18% quarter-over-quarter from -$3.8 million in Q1 2026.
Analysis
ENvue Medical (FEED) Income from Continuing Operations (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Income from Continuing Operations for 13 consecutive years, with -$4.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Continuing Operations fell 23.37% year-over-year to -$4.9 million in Q2 2026; TTM through Jun 2026 was $19.7 million, a 2531.32% increase from a year earlier, with the FY2025 full-year figure at $22.6 million, up 501.6% from the prior year.
- Income from Continuing Operations was -$4.9 million for Q2 2026 at ENvue Medical, down from -$3.8 million in the prior quarter.
- Over five years, Income from Continuing Operations peaked at $5.6 billion in Q4 2022 and troughed at -$4.9 million in Q2 2026.
- A 5-year average of $309.9 million and a median of -$976500.0 in 2022 frame the typical range for Income from Continuing Operations.
- The widest YoY moves for Income from Continuing Operations: up 21196.69% in 2022, down 502.78% in 2022.
- Over 5 years, Income from Continuing Operations stood at $5.6 billion in 2022, then tumbled by 99.88% to $6.7 million in 2023, then fell by 9.38% to $6.0 million in 2024, then surged by 363.17% to $27.9 million in 2025, then sank by 117.54% to -$4.9 million in 2026.
- The last three Income from Continuing Operations figures came in at -$4.9 million (Q2 2026), -$3.8 million (Q1 2026), and $27.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 201.00 Mn |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 | -4.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.90 Mn |
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | 27.93 Mn |
| Sep 30, 2025 | 510,000.00 |
| Jun 30, 2025 | -3.97 Mn |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | -998,000.00 |
| Jun 30, 2024 | -688,000.00 |
| Mar 31, 2024 | -588,000.00 |
| Dec 31, 2023 | 6.65 Mn |
| Sep 30, 2023 | -727,000.00 |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | 5.56 Bn |
| Sep 30, 2022 | -955,000.00 |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | 26.11 Mn |
| Sep 30, 2021 | -6.68 Mn |